122 filings
8-K
IVVD
Invivyd Inc
7 May 24
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19
7:38am
EFFECT
IVVD
Invivyd Inc
22 Apr 24
Notice of effectiveness
12:15am
ARS
2023 FY
IVVD
Invivyd Inc
18 Apr 24
Annual report to shareholders
4:15pm
DEF 14A
IVVD
Invivyd Inc
Definitive proxy
18 Apr 24
4:06pm
8-K
IVVD
Invivyd Inc
12 Apr 24
Invivyd Announces CEO Transition
7:36am
8-K
yy66c
4 Apr 24
Invivyd Provides PEMGARDATM Launch Update and Announces 2024 Net Product
5:25pm
8-K
ebvb5 y1r3an662v6
28 Mar 24
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
7:05am
8-K
cdy4wwg5ze9t8w
22 Mar 24
Invivyd Announces FDA Authorization for Emergency Use of PEMGARDAâ„¢ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19
8:58pm
8-K
jka i6t8dwrys7boswu
9 Feb 24
Index to Consolidated Financial Statements
4:01pm
8-K
khr5ddlae76x437h tnw
8 Jan 24
Other Events
7:12am
8-K
ozs91s4
3 Jan 24
Other Events
7:06am
8-K
7xkjzzg 9uh2
22 Dec 23
Entry into a Material Definitive Agreement
4:53pm
424B5
jc0d0xhlw7mx 3p
22 Dec 23
Prospectus supplement for primary offering
4:51pm
8-K
6hkh3vn11crbxctxd
18 Dec 23
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial
7:16am
8-K
vgg8 xsm9
9 Nov 23
Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
4:10pm
8-K
8vd002a5t0ujuz8g1l
11 Sep 23
Other Events
7:10am
8-K
dlj4rd54e lj52
5 Sep 23
Invivyd Appoints William Duke As Chief Financial Officer
7:05am